TYSABRI Adverse Event: Respiratory tract infection
TYSABRI Adverse Event: Respiratory tract infection is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TYSABRI; Product category: Drug; Primary reaction: Respiratory tract infection.
| Primary drug | TYSABRI |
|---|---|
| Product category | Drug |
| Primary reaction | Respiratory tract infection |
| All reactions | Respiratory tract infection; Staphylococcal infection; Bronchitis; Upper respiratory tract infection |
| Seriousness | Not serious |
| Patient outcome | Recovered/Resolved |
| Patient sex | Female |
| All drugs reported | TYSABRI |
| Reporter country | US |
| Reporter type | 3 |
| Report date | 20140313 |
| Report ID | 10005737 |
$299/mo
Try FDATracker →